Alpha DNA Investment Management’s Semtech SMTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,067
Closed -$437K 152
2024
Q4
$437K Buy
+7,067
New +$373K 0.17% 145
2022
Q2
Sell
-17,687
Closed -$1.23M 166
2022
Q1
$1.23M Buy
17,687
+130
+0.7% +$9.33K 0.86% 55
2021
Q4
$1.56M Sell
17,557
-825
-4% -$70.2K 0.99% 52
2021
Q3
$1.43M Sell
18,382
-3,268
-15% -$224K 0.97% 45
2021
Q2
$1.49M Buy
21,650
+12,340
+133% +$816K 1.02% 41
2021
Q1
$641K Buy
9,310
+1,964
+27% +$144K 0.74% 55
2020
Q4
$529K Buy
+7,346
New +$469K 0.56% 84

Other funds holding SMTC

Alpha DNA Investment Management's SMTC Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Semtech (SMTC) in Q1 2025, closing a stake of 7,067 shares — an estimated $437K sold.

Alpha DNA Investment Management first reported a position in SMTC in Q4 2020 and held it in 7 quarters. The position peaked at $1.56M in Q4 2021. 315 funds tracked by Wall St. Rank hold SMTC as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Semtech position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,067 Semtech shares in Q1 2025, an estimated $437K.
  • Alpha DNA Investment Management first reported a position in Semtech in Q4 2020 and held it in 7 quarters.
  • Alpha DNA Investment Management's Semtech position peaked at $1.56M in Q4 2021.
  • 315 funds tracked by Wall St. Rank held Semtech as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.